Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk

In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode 58: Neck Pain

In this episode of In the Clinic, the team discusses John Painica, a 52-year-old man presenting with neck pain.
Listen 0.5 credits available

In the Clinic Episode 57: Fibromyalgia

In this episode of In the Clinic, the team discusses Nadia Hench, a 49-year-old woman following up regarding achiness, fatigue, and poor sleep.
Listen 0.5 credits available

BS Medicine Episode #619: Scan, See, Decide: POCUS in the Evaluation of Dyspnea

In episode 619, Mike K and James chat yet again with Émélie Braschi. The topic this time is the use of point-of-care ultrasound (POCUS) to help diagnose patients coming into…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Dr. Tina Korownyk

Speakers do not have any conflicts of interest to declare.